Please login to the form below
Syneos Health announces partnership with AiCure
Will leverage proprietary intelligent software and AI-driven insights
FDA advisors say no to empagliflozin in type 1 diabetes
Approval of Boehringer, Lilly-partnered drug expansion looks unlikely
MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
Job losses will be across manufacturing and R&D divisions
Merck acquires pre-clinical biotech Calporta for up to $576m
Expands into early-stage neurodegeneration research field
World Diabetes Day 2019
Many lack knowledge around type 2 diabetes risk factors, says new survey
AbbVie sells $30bn of bonds ahead of Allergan merger
Will use net proceeds to fund cash consideration due to shareholders
Election 2019: Labour tops Tory pledge on NHS spending
Pledge comes as campaigning for upcoming election gathers steam
Nucala works in rare inflammatory disease, says GSK
Company is planning to file for approval in indication next year
Solid Bio falls as FDA halts DMD trial over safety concerns
Shares in the biotech dropped dramatically following the announcement
Q&A: Steve Clark
PME interviews the director of Redwood Brand Curators
-
Q&A: Chris McPhersonPME interviews ENGINE | MHP's account director, health
-
Q&A: Jessica PaceyPME interviews the founder and chief executive of newly launched health comms agency, 67health
-
ZPB Associates acquires PR specialist Journalista Agencies have previously worked together on a number of campaigns
-
BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancerPossible new treatment for difficult to treat cancer type
-
Merck claims first-ever okay for Ebola vaccine, in EuropeComes shortly after J&J filed its Ebola candidate with EMA
-
UK biotech Evgen craters on failed stroke trialShares in the biotech more than halved following the news
-
Otsuka presses on with Alzheimer’s agitation drug Surprise announcement comes on the heels of phase 3 trial fail
-
Sandoz expands into Japan with €400m Aspen deal Will gain presence in third largest generics market in the world
-
Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMAWill file for approval in US and other world markets before end of the year
Latest appointments
-
New faces at creative digital agency earthwareEmma Green and Melanie Charles join the team
-
New faces at Healthware Group and HRWThe latest movers in healthcare comms
-
New faces at Prime Global, Swordfish Advertising and Wilmington HealthcareThe latest movers in healthcare comms
-
New hires at Amgen, Eli Lilly and Zosano The latest movers in pharma
-
Red Consultancy appoints MD in its health divisionAvril Lee brings over 20 years' experience to company
Featured jobs
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Account Director, Medical Education
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- OTC / Consumer Health PR Account Director
-
profit share, pens, life assurance more
-
Account Executive
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Senior Medical Writer
-
Salary TBC
-
Account Supervisor
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director
-
Salary TBC
Subscribe to our email news alerts
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- Moving annual total (MAT)
- NICE backs first cannabis-based drugs, both from GW Pharma
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- Genital herpes vaccine candidate heads for human studies
- Is GSK planning to exit the respiratory business?
- OPEN Health Graduates and the XP Support Group
- Alexander Devine Website has gone live!
- Syneos Health announces partnership with AiCure
- FDA advisors say no to empagliflozin in type 1 diabetes
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- Merck acquires pre-clinical biotech Calporta for up to $576m
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- OPEN Health Graduates and the XP Support Group
- During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...
- Alexander Devine Website has gone live!
- As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
Quick links
Infographics
